
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Imagion Biosystems is a diagnostics & research business based in Australia. Imagion Biosystems shares (IBX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Imagion Biosystems has a trailing 12-month revenue of around $2.9 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Imagion Biosystems
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Imagion Biosystems . Find the share by name or ticker symbol: IBX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Imagion Biosystems reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Imagion Biosystems . Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
US stocks

Our top pick for
Overall broker

Our top pick for
Low-cost broker

What's in this guide?
Imagion Biosystems stock price (ASX:IBX)
Use our graph to track the performance of IBX stocks over time.Imagion Biosystems shares at a glance
52-week range | $0.026 - $0.105 |
---|---|
50-day moving average | $0.0388 |
200-day moving average | $0.0614 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.006 |
Compare share trading platforms
Is it a good time to buy Imagion Biosystems stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Imagion Biosystems price performance over time
Historical closes compared with the last close of A$0.044
1 week (2022-06-29) | 51.72% |
---|---|
1 month (2022-06-06) | 12.82% |
3 months (2022-04-06) | -24.14% |
6 months (2022-01-06) | -39.73% |
1 year (2021-07-06) | -53.19% |
---|---|
2 years (2020-07-06) | -2.22% |
5 years (2017-07-06) | -69.06% |
Imagion Biosystems financials
Revenue TTM | $2.9 million |
---|---|
Gross profit TTM | $151,534 |
Return on assets TTM | -26.63% |
Return on equity TTM | -45.96% |
Profit margin | -210.98% |
Book value | 0.012 |
Market capitalisation | $47.1 million |
TTM: trailing 12 months
Imagion Biosystems share dividends
We're not expecting Imagion Biosystems to pay a dividend over the next 12 months.
Imagion Biosystems share price volatility
Over the last 12 months, Imagion Biosystems 's shares have ranged in value from as little as $0.026 up to $0.105. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Imagion Biosystems 's is 3.0965. This would suggest that Imagion Biosystems 's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Imagion Biosystems overview
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.
Stocks similar to Imagion Biosystems
Imagion Biosystems in the news
Frequently asked questions
More guides on Finder
-
How to invest in the Australia Sunny Glass Group IPO
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
-
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
-
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
Ask an Expert